National Survey on Dyslipidemic Patients

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

NCT01025388 ·Status: COMPLETED

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

NCT01075594 ·Status: COMPLETED

Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand

NCT00684151 ·Status: COMPLETED

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

NCT06238466 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

NCT00327691 ·Status: COMPLETED ·Phase: PHASE4

Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States

NCT01031277 ·Status: COMPLETED

Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs

NCT07008794 ·Status: COMPLETED

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

NCT00536796 ·Status: COMPLETED

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

NCT01604733 ·Status: COMPLETED

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

NCT00536965 ·Status: COMPLETED

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

NCT05384262 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia

NCT02714569 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

NCT00812955 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

NCT07000136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

NCT03355027 ·Status: UNKNOWN ·Phase: NA

The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

NCT00656331 ·Status: WITHDRAWN ·Phase: NA

An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon

NCT01614561 ·Status: COMPLETED

Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion

NCT01126684 ·Status: COMPLETED ·Phase: NA

Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

NCT00722956 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Anacetrapib on Vascular Function and Arterial Stiffness

NCT02931188 ·Status: COMPLETED

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

NCT00327418 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia

NCT07034690 ·Status: RECRUITING ·Phase: PHASE4

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

NCT00143234 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

NCT04964557 ·Status: COMPLETED ·Phase: PHASE2

Study of A3309 in Patients With Dyslipidemia

NCT01069783 ·Status: COMPLETED ·Phase: PHASE2